Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer
Clinical trial NCT05086627 · COMPLETED
Trial details
- NCT number
- NCT05086627
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2024-07-30
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.